Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women
Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women
The purpose of this study is to evaluate the gastro-intestinal tolerability (nausea,
 vomiting, diarrhoea, abdominal discomfort, and abdominal pain) of vortioxetine following
 single oral doses of three modified-release (MR) capsules with differently coated multiple
 particles compared to one immediate-release (IR) tablet.
Inclusion Criteria:

 -  Healthy women ≥18 and ≤45 years of age with a body mass index (BMI) of >18.5 and <30.0
 kg/m2.

 -  Women will be of child-bearing potential with a confirmed non-pregnant and
 non-lactating status.

 Other protocol-defined Inclusion and Exclusion Criteria may apply.